mRNA vaccines rely heavily on Lipid Nanoparticles (LNPs)
It is a nanotechnology that took decades to refine, and acts as the crucial delivery system that enables mRNA molecules to access target cells. LNPs are currently the most advanced drug delivery vehicle in the clinic. But they also have drawbacks such as possible toxicity and sub-optimal cellular penetration. Or viral vectors, which can cause side effects.